Leading the way to safer medication
 Crosscheck  Recommender

Ambroxol

Description

Ambroxol induces activation of the surfactant system by acting directly on the type II pneumocytes of the alveoles and the Clara cells in the region of the small airways. It promotes the formation and outward transfer of surface-active material in the alveolar and bronchial region of the foetal and adult lungs.

ATC Classification

Code
Title
Category
R05CB06
Ambroxol
R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CB Mucolytics

Trade names

Trade name
Countries

Austria

Austria

Austria

Singapore

Spain

Singapore

Spain

Spain

Cyprus

Cyprus

Cyprus

Cyprus

Spain

Spain

Austria Netherlands

Cyprus

Singapore

Austria Spain

Austria Cyprus Singapore

Spain

France

Singapore

Singapore

France

Trade names (in combination): MUCOSPAS

Product Monographs

Monograph
Type
Country
FLAVAMED HUSTENSAFT Oral solution
MPI, EU: SmPC